Year | Detail |
Founding story |
Boston Scientific Corp. has been established as a holding company in 1979. |
1970s |
The company's steerable catheters were firstly used in less-invasive procedures. In early 1970s, the company also introduced various new products such as Zavala Lung Model and lung cytology brush. |
1980s |
|
|
Boston Scientific Corp. has acquired Kimray Medical Associates (KMA). |
|
In 1981, the company acquired Endo-Tech, who is a provider of gastrointestinal and pulmonary endoscopic accessories. |
|
In 1988, the introduction of Van-Tech has boosted the urology business with products such as pigtail ureteral stent. |
1990s |
|
|
In May 19, 1992, Boston Scientific Corp. went into public through an IPO. |
|
By 1997, Boston Scientific Corp. has acquired nine companies with a revenue of around $1.8 billion. |
|
In 1998, Boston Scientific Corp. acquired Schneider Worldwide, which added necessary catheter and stent technologies to Boston Scientific's work in the area. |
2000s |
In 2004, Boston Scientific Corp. launched the TAXUS Express2, a paclitaxel-eluting coronary stent system in the U.S. |
|
The company also manufactured pulse generators and pain management systems. |
|
In 2004, the acquisition of Advanced Bionics has allowed company to enter into Neuromodulation. |
|
In 2006, the acquisition of Guidant has enabled company to be one of the leading company for cardiovascular medicines and largest medical devices globally. |
2010s |
|
|
Boston Scientific Corp. launched Promus Element, a drug-eluting coronary stent system; S-ICD System, a subcutaneous implantable defibrillator; Alair Bronchial Thermplasty System used for the treatment of asthma; and Precision Plus Spinal Cord Stimulation System, which will be used to manage chronic pain of the trunk and limbs. |